What amount sold does Bioverge Funds, Contraline II, LLC report in Form D filings?

The latest linked filings report $125K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Bioverge Funds, Contraline II, LLC's most recent SEC filing?

Bioverge Funds, Contraline II, LLC's most recent Form D filing was on 2022-11-03.

How many investors does Bioverge Funds, Contraline II, LLC have?

The most recent Form D filing lists 11 investor(s).

Bioverge Funds, Contraline II, LLC

CIK: 0001952836·Investing·BOISE, ID·Limited Liability Company·Founded 2022

Reported Sold

$124,500

Total Filings

Identified Offerings

Last Filed

Nov 3, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Investing industry

SEC EDGAR

Offering filing timeline

Nov 3, 2022Form D — New notice

Reported sold: $124,500 · Target: $150,000

Rule 506(b)·11 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Not Applicable

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$124,500

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Neil Bioverge Funds Management,LLC - Littman

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 3, 2022	New	$150,000	$124,500	11

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Freedom FCG Investment Partners VI LLC

Investing

Offering target: $114,705

Filed Jul 28, 2026